330 related articles for article (PubMed ID: 24436311)
21. Tumor necrosis factor, interleukin 11, and leukemia inhibitory factor produced by Langerhans cells in Langerhans cell histiocytosis.
Andersson By U; Tani E; Andersson U; Henter JI
J Pediatr Hematol Oncol; 2004 Nov; 26(11):706-11. PubMed ID: 15543003
[TBL] [Abstract][Full Text] [Related]
22. ddPCR Analysis Reveals BRAF V600E Mutations Are Infrequent in Isolated Pituitary Langerhans Cell Histiocytosis Patients.
Nellan A; Bodlak A; Mirsky DM; Mulcahy Levy J; Garrington TP; Foreman NK; Gilani A; Hayashi M
J Neuropathol Exp Neurol; 2020 Dec; 79(12):1313-1319. PubMed ID: 32930721
[TBL] [Abstract][Full Text] [Related]
23. BRAFV600E mutation in cutaneous lesions of patients with adult Langerhans cell histiocytosis.
Varga E; Korom I; Polyánka H; Szabó K; Széll M; Baltás E; Bata-Csörgő Z; Kemény L; Oláh J
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1205-11. PubMed ID: 25351766
[TBL] [Abstract][Full Text] [Related]
24. [Pathophysiology and treatment of adult Langerhans cell histiocytosis].
Tojo A; Kobayashi M
Rinsho Ketsueki; 2020; 61(9):1028-1034. PubMed ID: 33162496
[TBL] [Abstract][Full Text] [Related]
25. Oral manifestations of Langerhans cell histiocytosis with unusual histomorphologic features.
AbdullGaffar B; Awadhi F
Ann Diagn Pathol; 2020 Aug; 47():151536. PubMed ID: 32454442
[TBL] [Abstract][Full Text] [Related]
26. Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis.
Annels NE; Da Costa CE; Prins FA; Willemze A; Hogendoorn PC; Egeler RM
J Exp Med; 2003 May; 197(10):1385-90. PubMed ID: 12743170
[TBL] [Abstract][Full Text] [Related]
27. Recent advances in Langerhans cell histiocytosis.
Morimoto A; Oh Y; Shioda Y; Kudo K; Imamura T
Pediatr Int; 2014 Aug; 56(4):451-61. PubMed ID: 24840547
[TBL] [Abstract][Full Text] [Related]
28.
El Sissy FN; Lorillon G; Mandonnet E; Polivka M; Addle-Biassette H; Emile JF
Clin Neuropathol; 2020; 39(2):64-69. PubMed ID: 31661070
[TBL] [Abstract][Full Text] [Related]
29. Langerhans Cell Histiocytosis Associated With Underlying Hematolymphoid Disorders in Adults: Report of 2 Cases and Review of the Literature.
Kiavash K; Malone JC
Am J Dermatopathol; 2018 Aug; 40(8):588-593. PubMed ID: 30035752
[TBL] [Abstract][Full Text] [Related]
30. Pediatric Langerhans cell histiocytosis: state of the science and future directions.
Thacker NH; Abla O
Clin Adv Hematol Oncol; 2019 Feb; 17(2):122-131. PubMed ID: 30845115
[TBL] [Abstract][Full Text] [Related]
31. Langerhans cell histiocytosis: a cytokine/chemokine-mediated disorder?
Garabedian L; Struyf S; Opdenakker G; Sozzani S; Van Damme J; Laureys G
Eur Cytokine Netw; 2011 Sep; 22(3):148-53. PubMed ID: 22001902
[TBL] [Abstract][Full Text] [Related]
32. Differentiation of Langerhans cells in Langerhans cell histiocytosis.
Geissmann F; Lepelletier Y; Fraitag S; Valladeau J; Bodemer C; Debré M; Leborgne M; Saeland S; Brousse N
Blood; 2001 Mar; 97(5):1241-8. PubMed ID: 11222366
[TBL] [Abstract][Full Text] [Related]
33. Squash smear cytology of Langerhans cell histiocytosis.
Nahm JH; Yoon G; Do SI; Kim HS
Int J Clin Exp Pathol; 2015; 8(7):7998-8007. PubMed ID: 26339366
[TBL] [Abstract][Full Text] [Related]
34. Langerhans cell histiocytosis and Erdheim-Chester disease, both with cutaneous presentations, and papillary thyroid carcinoma all harboring the BRAF(V600E) mutation.
Johnson WT; Patel P; Hernandez A; Grandinetti LM; Huen AC; Marks S; Ho J; Monaco SE; Jaffe R; Picarsic J
J Cutan Pathol; 2016 Mar; 43(3):270-5. PubMed ID: 26454140
[TBL] [Abstract][Full Text] [Related]
35. Association between clinicopathologic characteristics and BRAF
Huang H; Lu T; Sun Y; Li S; Li J; Xu K; Feng RE; Xu ZJ
Thorac Cancer; 2019 Oct; 10(10):1984-1992. PubMed ID: 31441596
[TBL] [Abstract][Full Text] [Related]
36. Neonatal and early infantile cutaneous langerhans cell histiocytosis: comparison of self-regressive and non-self-regressive forms.
Battistella M; Fraitag S; Teillac DH; Brousse N; de Prost Y; Bodemer C
Arch Dermatol; 2010 Feb; 146(2):149-56. PubMed ID: 20157025
[TBL] [Abstract][Full Text] [Related]
37. [Pathogenesis of adult pulmonary Langerhans-cell histiocytosis].
Tazi A; Soler P; Hance AJ
Rev Mal Respir; 1999 Apr; 16(2):151-9. PubMed ID: 10339758
[TBL] [Abstract][Full Text] [Related]
38. Circulating cell-free BRAF
Héritier S; Hélias-Rodzewicz Z; Lapillonne H; Terrones N; Garrigou S; Normand C; Barkaoui MA; Miron J; Plat G; Aladjidi N; Pagnier A; Deville A; Gillibert-Yvert M; Moshous D; Lefèvre-Utile A; Lutun A; Paillard C; Thomas C; Jeziorski E; Nizard P; Taly V; Emile JF; Donadieu J
Br J Haematol; 2017 Aug; 178(3):457-467. PubMed ID: 28444728
[TBL] [Abstract][Full Text] [Related]
39. Morphoproteomics provides support for TGF-β pathway signaling in the osteoclastogenesis and immune dysregulation of osteolytic Langerhans cell histiocytosis.
Alexandrescu S; Tatevian N; Czerniak BA; Covinsky MH; Burns NK; Brown RE
Int J Clin Exp Pathol; 2012; 5(6):503-11. PubMed ID: 22949932
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous adult xanthogranuloma with a small portion of BRAF
Ishikawa M; Endo Y; Uehara A; Suto M; Yasuda M; Motegi SI; Ishikawa O
J Dermatol; 2019 Feb; 46(2):161-165. PubMed ID: 30536719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]